Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-24-000180

Chief Financial Officer gave up 10,099 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Goeltz II Robert C. Chief Financial Officer 2024-12-15 Shares withheld for taxes −10,099 $16.08 $162,392 63,732 D: show line 1 in the form
Loading xslF345X05/wk-form4_1734485773.xml…